PATENT CLAIM ANALYSIS

Application Number: 16007671
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "017500"]

Abstract:
The present invention pertains to novel uses of endomorphine-1 peptide, analogs, and salts thereof for therapy of children, patients currently suffering from drug addiction, patients prone to opioid addiction, and patients with chemo-induced pain.

Claim (Index 3):
The method, according to  claim 1 , wherein the subject is a human.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 94.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15439813', '13477423', '14354092', '13003761', '14622660']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7270555184705246
- 35 USC 102 Novelty (BERT): 0.5225866224612422
- Combined Prediction Score: 0.7066086288695964
- Mean Citation Score: 209.60784400000003
- Max Citation Score: 217.47653
- Similarity Product: 101.01344955617635

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test